Robert Steinmetz, MD
Ophthalmology · Tallahassee, FLNPI 1194782508
Payments from drug & device makers
Across 166 payments — averaging $4470.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$505K
- Kyowa Kirin, Inc.$199K
- US Retina LLC$28K
- Janssen Global Services, LLC$8K
- Genentech USA, Inc.$309
- Regeneron Healthcare Solutions, Inc.$305
- plus $560 from 7 others
Across 2 payments — averaging $4232.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Global Services, LLC$8K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 40 | $504,945 |
| Kyowa Kirin, Inc. | 59 | $199,304 |
| US Retina LLC | 12 | $28,154 |
| Janssen Global Services, LLC | 2 | $8,465 |
| Genentech USA, Inc. | 15 | $309 |
| Regeneron Healthcare Solutions, Inc. | 10 | $305 |
| AbbVie(2 entities) | 11 | $235 |
| Novartis | 7 | $112 |
| Astellas Pharma US Inc | 4 | $82 |
| Apellis Pharmaceuticals, Inc. | 3 | $64 |
| Biogen | 1 | $27 |
| Olympus America Inc. | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $16 |
How this compares
$742,041 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Tallahassee
- Harold BrooksTallahassee$3.5M
- Charles NewellTallahassee$780K
- Nicholas FarberTallahassee$406K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.